menu_open Columnists
Jeffrey Goldfarb

Jeffrey Goldfarb

Reuters

We use cookies to provide some features and experiences in QOSHE

More information  .  Close

Lazard’s turnaround pales next to M&A boom

Lazard’s turnaround pales next to M&A boom
24.07.2026 3

Reuters

Jeffrey Goldfarb

Stale antitrust fixes yield a rotten Deere deal

16.07.2026 8

Reuters

Jeffrey Goldfarb

Gamification gone wild tempts Tobin taxes galore

07.07.2026 7

Reuters

Jeffrey Goldfarb

Jack Daniel’s days of drinking alone are numbered

02.07.2026 10

Reuters

Jeffrey Goldfarb

JPMorgan succession race gives Spinal Tap vibes

26.06.2026 10

Reuters

Jeffrey Goldfarb

SpaceX seals private market’s triumph over public

19.05.2026 20

Reuters

Jeffrey Goldfarb

‘Private equity’ cries out for a rebranding

18.05.2026 40

Reuters

Jeffrey Goldfarb

Shaky US farmers put Syngenta in trade crossfire

22.04.2026 40

Reuters

Jeffrey Goldfarb

QXO's $17 bln expansion hinges on raising the roof

20.04.2026 20

Reuters

Jeffrey Goldfarb

AI dreams crash into stark $7 trln reality

06.04.2026 30

Reuters

Jeffrey Goldfarb

Longer Jefferies courtship would benefit Sumitomo

24.03.2026 30

Reuters

Jeffrey Goldfarb

Cash-and-stock mixers sweeten M&A spirits

24.02.2026 20

Reuters

Jeffrey Goldfarb

Super Bowl primes sports to be streaming MVP

06.02.2026 20

Reuters

Jeffrey Goldfarb

Boutique bank deal energizes heartland finance

27.01.2026 30

Reuters

Jeffrey Goldfarb

Get ready for the biggest M&A deal ever

17.12.2025 20

Reuters

Jeffrey Goldfarb

Hottest 2026 board member? Artie Fishlin Telijentz

16.12.2025 30

Reuters

Jeffrey Goldfarb

Endangering bears lets AI animal spirits run wild

03.12.2025 40

Reuters

Jeffrey Goldfarb

Business-travel IPO depends on AI slipstream

22.10.2025 20

Reuters

Jeffrey Goldfarb

Figma IPO sketches case for direct listings

01.08.2025 20

Reuters

Jeffrey Goldfarb

Rail deal puts America first and shareholders last

29.07.2025 20

Reuters

Jeffrey Goldfarb

Netscape IPO casts a shadow from 1995 over AI boom

24.07.2025 40

Reuters

Jeffrey Goldfarb

Jamie Dimon overstretches his fintech flex

18.07.2025 30

Reuters

Jeffrey Goldfarb

Biotech nears cure for Chinese corporate epidemic

19.06.2025 20

Reuters

Jeffrey Goldfarb

Private equity’s nightmare on Main Street: podcast

11.06.2025 40

Reuters

Jeffrey Goldfarb

SPACs trigger bad case of Wall Street amnesia

29.05.2025 20

Reuters

Jeffrey Goldfarb

Capital intensity will reprogram Big Tech values

08.05.2025 20

Reuters

Jeffrey Goldfarb